计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R648399-5mg |
5mg |
期货 ![]() |
| |
| R648399-10mg |
10mg |
期货 ![]() |
| |
| R648399-25mg |
25mg |
期货 ![]() |
| |
| R648399-50mg |
50mg |
期货 ![]() |
|
| 别名 | 伦替普利消旋体 |
|---|---|
| 英文别名 | DTXSID10868597 | 2-(2-hydroxyphenyl)-3-(3-mercaptopropanoyl)thiazolidine-4-carboxylic acid | 2-(2'-Hydroxyphenyl)-3-(3-mercaptopropanoyl)-4-thiazolidine carboxylic acid | SA 446 | AKOS040742537 | 4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mer |
| 规格或纯度 | ≥98% |
| 英文名称 | Rentiapril racemate |
| 生化机理 | 消旋伦替普利(SA-446消旋体)是伦替普利的消旋体。伦替普利是一种血管紧张素转换酶(ACE)抑制剂。 |
| 储存温度 | 2-8°C储存,避光,干燥 |
| 运输条件 | 冰袋运输 |
| 产品介绍 |
Rentiapril racemate (SA-446 racemate) is the racemate of Rentiapril. Rentiapril is an angiotensin converting enzyme ( ACE ) inhibitor. In Vivo A three-months toxicity study of an angiotensin converting enzyme (ACE) inhibitor, Rentiapril (CAS 80830-42-8), is performed in Sprague-Dawley rats by oral administration. The dose levels of 0, 30, 125, 500 and 1000 mg/kg are tested in both sexes, in which each experimental group comprised 10 rats. Another ACE inhibitor, captopril, is used as a reference compound. Rentiapril at the highest dose of 1000 mg/kg causes low food consumption and death of some animals with signs of bloody feces and anemia. In males and females receiving 500 and 1000 mg/kg, there are low body weight gain, increases in water intake, urine volume and serum BUN level, and decreases in levels of various erythrocytic parameters. Kidney weight is increased dose-dependently in both sexes. Histopathologically, renal changes in the 500 and 1000 mg/kg groups consist of proximal tubular degeneration, juxtaglomerular cell hyperplasia and interstitial cell infiltration. Similar, but mild, changes in proximal tubules are present in the female 125 mg/kg group. Dead animals from the highest dose groups further show gastrointestinal hemorrhagic erosion and/or ulcer, decrease bone marrow erythropoiesis and hepatocytic vacuolar degeneration. There is no pathological alteration in rats from other Rentiapril-treated groups, as well as in controls. These results indicate that the no-effect dose of Rentiapril in rats by three months oral administration is 30 mg/kg in female and 125 mg/kg in male . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Angiotensin converting enzyme (ACE) |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid |
| INCHI | 1S/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18) |
| InChi Key | BSHDUMDXSRLRBI-UHFFFAOYSA-N |
| Smiles | C1C(N(C(S1)C2=CC=CC=C2O)C(=O)CCS)C(=O)O |
| Isomeric SMILES | C1C(N(C(S1)C2=CC=CC=C2O)C(=O)CCS)C(=O)O |
| 关联CAS | 72679-47-1 |
| PubChem CID | 122113 |
| MeSH Entry Terms | 2-(2'-hydroxyphenyl)-3-(3-mercaptopropanoyl)-4-thiazolidine carboxylic acid;rentiapril;rentiapril, (2R-cis)-isomer;SA 446;SA-446 |
| 分子量 | 313.39 |
| 溶解性 | DMSO : 100 mg/mL (319.09 mM; Need ultrasonic) |
|---|---|
| 分子量 | 313.400 g/mol |
| XLogP3 | 1.300 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 313.044 Da |
| 单同位素质量Monoisotopic Mass | 313.044 Da |
| 拓扑极表面积Topological Polar Surface Area | 104.000 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 379.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 2 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |